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Gap Junctions: Basic Structure and Function
Gu¨listan Mes¸e1, Gabriele Richard2 and Thomas W. White1,3
Gap junctions allow the exchange of ions, second messengers, and small metabolites between adjacent cells
and are formed by two unrelated protein families, the pannexins and connexins. Mutations in connexin genes
cause a variety of genetic disorders, implicating a critical role in tissue homeostasis. Association of congenital
skin disorders to mutations in different connexins has underscored the importance of gap junctional
communication in the skin and its appendages. Here, we discuss the basic structure of gap junction channels
and the function of connexin genes that have been associated with human disorders to explore the physiology
of intercellular communication in skin.
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Introduction
Cellular communication is important
for the maintenance of tissue/organ
homeostasis in multicellular organisms.
Using this communication, cells can
review differences in environmental
conditions and respond accordingly.
This concept could involve either
sending a signal to neighboring cells
to generate a coordinated response or
isolating groups of cells from the rest of
the community to maintain tissue
integrity. One type of communication
between cells is mediated via intercel-
lular channels that cluster in specia-
lized regions of the plasma membrane
to form gap junctions (Robertson, 1963;
Revel and Karnovsky, 1967; Wei et al.,
2004). Gap junctional channels link
the cytoplasm of two cells, and provide
a means for the exchange of ions (Kþ
and Ca2þ ), second messengers (cAMP,
cGMP, and inositol 1,4,5-triphosphate
(IP3)), and small metabolites (glucose),
allowing electrical and biochemical
coupling between cells (Kanno and
Loewenstein, 1964; Lawrence et al.,
1978). Furthermore, Valiunas et al.
(2005) recently showed that transfer of
small interference RNAs between ad-
jacent cells through gap junctions was
possible, although it remains unclear if
small interfering RNAs are normally
exchanged in vivo. Gap junctional
communication is essential for many
physiological events, including cell
synchronization, differentiation, cell
growth, and metabolic coordination of
avascular organs including epidermis
and lens (White and Paul, 1999;
Vinken et al., 2006).
Gap junctions are present in both
vertebrates and invertebrates from me-
sozoa to mammals, whereas higher
plants use structures called ‘‘plasmo-
desmata’’ for direct intercellular com-
munication. In chordate animals, gap
junction channels are encoded by a
family of genes called ‘‘connexins’’
(Goodenough, 1974), which can be
categorized into three groups known as
a, b, and g according to their gene
structure, overall gene homology, and
specific sequence motifs (Harris, 2001).
There are two conventions of nomen-
clature in the literature for connexins,
one of which depends on molecular
mass of the connexin (Cx26 represents
the connexin protein of 26 kDa; Cx46,
connexin isoform of 46 kDa, etc),
whereas the other uses greek symbols
based on evolutionary considerations
(GJB2 is gap junction beta 2 referring to
Cx26, whereas GJA3 stands for gap
junction alpha 3, or Cx46). Gap junc-
tional communication in nonchordate
animals, however, is mediated via
another family of integral membrane
proteins called innexins (Inxs). Innexin
proteins are not homologous to con-
nexins in terms of primary sequence;
nevertheless, gap junction channels
formed from innexins share functional
similarities with intercellular channels
made of connexins. Recently, another
group of proteins called pannexins
(Panxs), which may be distantly related
to innexins, were identified in verte-
brates and have been shown to be
expressed in various tissues including
kidney, eye, and neurons (Panchin,
2005; Barbe et al., 2006). So far, only
connexin genes have been linked to
human diseases, so we will limit our
discussion to the structure and function
of gap junctions that are formed by the
connexins.
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Basic structural organization of
connexins and gap junctions
Gap junctions are highly specialized
membrane structures that contain clus-
ters of channels. This organization
requires the membranes of two neigh-
boring cells to come close to each
other leaving a 2–4 nm gap (Bruzzone
et al., 1996; White and Paul, 1999).
Connexin family members share a
similar structural topology. Each con-
nexin has four transmembrane domains
that constitute the wall/pore of the
channels. These domains are con-
nected by two extracellular loops that
play roles in the cell–cell recognition
and docking processes. There are three
unchanged cysteine residues in each
loop, which solely form intraconnexin
disulfide bonds (Krutovskikh and
Yamasaki, 2000). The transmembrane
domains and the extracellular loops are
highly conserved among the family
members. Furthermore, connexin pro-
teins have cytoplasmic N- and C-
termini and a cytoplasmic loop linking
the second and third transmembrane
domains (Figure 1a). Although the N-
terminus is conserved, the cytoplasmic
loop and C-terminus show great varia-
tion in terms of sequence and length.
For example, the Cx26 protein has the
shortest C-terminus, whereas Cx50 has
a long C-terminal tail. The cytoplasmic
tail and loop are susceptible to various
post-translational modifications (e.g.
phosphorylation), which are believed
to have regulatory roles (Cruciani and
Mikalsen, 2002). Most connexins are
phosphoproteins, and phosphorylation
is considered to be important for the
regulation of assembly and modulation
of the physiological properties of the
channels (Lampe and Lau, 2004; King
and Lampe, 2005).
Gap junction biosynthesis and as-
sembly are strictly regulated and inter-
cellular junctions have a short half-life
of only a few hours (Musil et al., 2000).
Most connexins are cotranslationally
integrated into the endoplasmic reticu-
lum membrane. The oligomerization of
six connexins into a hemichannel is
thought to occur in a progressive
fashion starting in the endoplasmic
reticulum and ending in the trans-Golgi
network (Musil and Goodenough,
1993; Sarma et al., 2002; Laird,
2006). Connexons (hemichannels) are
then carried to the cell surface via
vesicles transported through microtu-
bules, which fuse to the plasma mem-
brane. These hemichannels can either
form nonjunctional channels in unop-
posed areas of the cell membrane (see
below) or diffuse freely to regions of
cell-to-cell contact to find a partner
connexon from a neighboring cell to
complete the formation of intercellular
channels (Figure 1b) (Harris, 2001).
Intercellular channels then cluster into
gap junction plaques, a highly dynamic
event involving removal of old chan-
nels from the center of the plaque,
while adding new gap junction sub-
units to the periphery (Gaietta et al.,
2002). The intercellular channels from
the middle of the plaque are interna-
lized into vesicular structures called
‘‘annular junctions’’ (Jordan et al.,
2001), which either fuse with the
lysosome for degradation by lysosomal
enzymes or are targeted to the proteo-
somal pathway (Laing and Beyer, 1995;
Musil et al., 2000; Qin et al., 2003).
The continuous synthesis and degrada-
tion of connexins through these me-
chanisms may provide for the quick
adaptation of tissues to changing en-
vironmental conditions. Unopposed
hemichannels can also be functional
under certain conditions, including
mechanical and ischemic stress. Under
these circumstances, open hemichan-
nels are thought to facilitate the release
of a variety of factors such as ATP,
glutamate, and NADþ into the extra-
cellular space, generating different
physiological responses (Evans et al.,
2006). It is currently not known if
active hemichannels become incorpo-
rated into gap junctions before degra-
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Figure 1. Schematic representation of connexins and gap junction channels. (a) Connexins have four transmembrane domains, two extracellular loops, a
cytoplasmic loop, and cytoplasmic N- and C-termini. (b) Six connexins oligomerize to form hemichannels called ‘‘connexons,’’ which then align in the
extracellular space to complete the formation of gap junction channels. Different connexins can selectively interact with each other to form homomeric,
heteromeric, and heterotypic channels, which differ in their content and spatial arrangement of connexin subunits.
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dation or follow a distinct recycling
pathway.
There are at least 21 connexin iso-
forms in the human genome and nearly
all cells in the body express at least one
type of these genes at some point
during development and in the adult
life. For instance, Cx26 is highly
expressed in cochlea, liver, skin, and
placenta, while Cx46 and Cx50
are exclusively found in the eye. More-
over, connexins show overlapping
expression patterns where an indivi-
dual cell can use more than one type of
isoform. Cx26, Cx30, Cx30.3, Cx31,
Cx43, and others, for example, are
found in keratinocytes (Wiszniewski
et al., 2000; Kretz et al., 2003),
whereas cardiomyocytes use Cx31.9,
Cx40, Cx43, and Cx45 for intercellular
communication (Beyer et al., 1995;
Bukauskas et al., 2006). Coexpression
of multiple genes within a single cell,
consequently, can affect both the com-
position of connexons and intercellular
channels formed and may provide a
compensatory mechanism for the loss
of one isoform. Connexons can be
formed either from a single type of
connexin or from more than one type,
leading to the formation of either
homomeric or heteromeric hemichan-
nels, respectively. Another complexity
is observed during the formation of the
fully functional channels. Homotypic
channels are formed from either the
same homomeric or the same hetero-
meric connexons, whereas heterotypic
channels contain different homomeric
or heteromeric hemichannels (Figure
1b). The formation of these structures
depends on the compatibility of con-
nexins forming the channels, since not
all connexins can interact with each
other, such as Cx26 was shown to form
heteromeric channels with Cx30 and
Cx32, whereas it cannot form func-
tional channels with Cx40 (Segretain
and Falk, 2004). These complex inter-
actions thus increase the structural and
functional diversity, allowing a vast
array of possibilities in the type of
molecules shared between cells.
Permselectivity of gap junctions
Early models of gap junctional com-
munication described the channels as
being nonspecific passive pores, which
would freely allow the passage of any
ions or metabolites smaller than
1.2 kDa (Simpson et al., 1977). How-
ever, recent developments in the field
highlighted the selective permeability
(permselectivity) of gap junction chan-
nels, demonstrating that channels
formed by different connexins are
unique in terms of their conductance,
gating, and permeability to specific
molecules (Goldberg et al., 2004)
(Figure 2). Furthermore, the association
of diseases to specific connexins has
also emphasized the uniqueness of
each protein, because the loss of one
isoform cannot be compensated for by
the presence of other connexins in the
same tissue or a cell type and leads to
pathophysiological defects. Gap junc-
tions mediate the transfer of ions and
metabolites/second messengers be-
tween cells, allowing ionic and bio-
chemical coupling, respectively. In
excitable cells such as neurons and
heart, electrical coupling enables the
generation of synchronized and rapid
responses. In nonexcitable cells, the
metabolic coupling may play role in
the propagation of coordinated
responses. To date, the ionic perme-
ability of gap junctions made of differ-
ent connexins has been shown to be
similar to each other, presenting only
minor alterations (Nicholson et al.,
2000; Harris, 2001). On the other
hand, diverse connexins demonstrated
differences in the exchange of larger
metabolites and second messengers
(Nicholson et al., 2000; Goldberg
et al., 2004; Weber et al., 2004). This
characteristic of connexins could ex-
plain why different tissues need differ-
ent types of intercellular channels.
Bevans et al. (1998) were one of the
first to demonstrate variation in the
permeability of connexins to distinct
signaling molecules. They reconstituted
liposomes with either Cx32 homomeric
or Cx26/Cx32 heteromeric hemichan-
nels and then loaded the liposomes
with tritiated cAMP and cGMP. Using
transport-specific fractionation, they
determined the permeabilities of these
second messengers through the recon-
stituted channels and observed that
Cx32 homomeric hemichannels were
equally permeable to both cAMP and
cGMP, whereas the Cx26/Cx32 hetero-
meric channels favored the passage of
cGMP over cAMP (Figure 2a).
In another study, Goldberg et al.
(2002) compared the permeability of
Cx32 and Cx43 to different cellular
metabolites, including glutamate,
glucose, adenosine, AMP, ADP, ATP,
and glutathione. They developed a
layered culture system using a porous
membrane to separate donor and re-
ceiver cells from each other, while still
allowing the formation of gap junctions
between these cells. This study demons-
trated that Cx32 gap junctions had a
10-fold higher relative permeability to
adenosine compared with Cx43 chan-
nels. By contrast, the phosphorylation
status of the adenosine shifted its
cAMPa
b
cGMP Cx32
cAMP
cGMP
Cx32 + Cx26
Adenosine AMP ADP ATP
Cx43
Cx32
Figure 2. Selective permeability of gap junctions to second messengers. (a) Gap junctions are unique in
terms of permeability. Cx32 hemichannels were permeable to both cAMP and cGMP whereas Cx26/
Cx32 heteromeric hemichannels showed reduced transfer of cAMP but their permeability to cGMP was
comparable to that of Cx32 hemichannels. (b) The addition of extra phosphate groups to adenosine
changed its relative permeability through gap junctions. Cx32 intercellular channels were more
permeable to adenosine than channels formed by Cx43. However, the Cx43 intercellular channels had
progressively higher permeability to AMP, ADP, and ATP than those formed by Cx32.
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preferential selectivity from Cx32 chan-
nels toward those formed by Cx43. The
Cx43 intercellular channels were eight
times more permeable to AMP and
ADP than Cx32 channels, and the
permeability of ATP through Cx43
was more than 300-fold better than
that through Cx32 channels (Figure 2b).
These observations may suggest an
effect of charge and size on the
permselectivity of the molecule. How-
ever, Goldberg et al. (1999) had shown
earlier that Cx32 intercellular channels
were more permeable to calcein, a
fluorescent dye with higher molecular
weight and charge (MW: 623 and
charge: 4) than ATP (MW: 507 and
charge: 3), relative to the Cx43
channels. These data suggest the pre-
sence of determinants of gap junctional
permselectivity, in addition to the size
and the charge of the molecule.
The concept that each gap junction
channel is unique in terms of perms-
electivity is supported by a large
number of studies. This specificity is
well demonstrated in connexin-asso-
ciated diseases, where loss of one
isoform cannot be compensated for by
coexpressed connexins. Beltramello
et al. (2005) compared the permeability
of wild-type Cx26 and deafness-asso-
ciated Cx26 mutant V84L channels to
IP3. Initially, they observed that both
wild type and mutant channels were
equally permeable to Kþ ions. Then,
they extended their experiments to test
if the passage of IP3 between wild type
or mutant channels was altered.
Although mutant V84L channels were
permeable to potassium ions, the IP3
transfer was impaired between the cells
expressing the mutant protein. The
authors also analyzed the permeability
of Cx30 to IP3 and determined that the
permeability coefficient of Cx30 was
approximately half that of wild-type
Cx26. Hence, this suggests that even
though Cx30 is highly homologous to
Cx26, they are not functionally redun-
dant and Cx30 may not be able to
compensate for the loss of IP3 exchange
between the cochlear supporting cells
in the absence of Cx26 (Beltramello
et al., 2005). Furthermore, Zhang et al.
(2005) examined the passage of IP3 and
Ca2þ waves in organotypic cochlear
cultures to analyze if biochemical
coupling through gap junctions was
needed for normal cochlear function.
When they injected IP3 into the wild-
type cells, they observed the generation
of Ca2þ waves in the cells around the
injected one. However, when they
analyzed the deafness-causing mutants,
V84L, V95M, and A88S, they observed
a decrease in the intercellular transfer
of propidium iodide and IP3. These
mutant gap junctions were still perme-
able to Naþ and Ca2þ when they
injected cells directly with these ions
and detected their diffusion with fluor-
escent dyes (Zhang et al., 2005). This
suggested that although some of the
deafness-causing Cx26 mutant chan-
nels still retained their ionic coupling,
they had altered permeability to larger
metabolites, which may play role in the
etiology of the disease.
Gap junctional communication in skin
Connexins play a key role in tissue/
organ homeostasis and the etiology of
several human hereditary diseases was
linked to mutations in connexin genes.
The epidermis is highly coupled by
intercellular channels and gap junc-
tional communication plays a crucial
role in keratinocyte growth and differ-
entiation. At least nine connexin genes,
including Cx26, Cx30, Cx30.3, Cx31,
and Cx43 were shown to be expressed
during the keratinocyte differentiation
process (Kelsell et al., 2000; Di et al.,
2001). These genes show distinct spatial
and temporal expression patterns as
well as some overlapping tissue dis-
tribution during epidermal morphogen-
esis. Cx43 is expressed throughout the
interfollicular epidermis, whereas Cx26
is only present in palmoplantar epider-
mis. Cx26 and Cx43 are also expressed
in the hair follicles and sweat glands
(Salomon et al., 1994). Additionally,
Cx30, Cx30.3, and Cx31 have been
found in the upper, differentiated epi-
dermal layers. Although the exact role
of gap junctional communication dur-
ing keratinocyte differentiation is not
exactly known, the association of muta-
tions in the genes for Cx26, Cx30,
Cx30.3, Cx31, and Cx43 with different
skin pathologies emphasized the im-
portance of intercellular communica-
tion in the development and
differentiation of epidermis (Richard,
2005). The first hereditary skin disease
associated with connexin genes was
erythrokeratodermia variabilis (EKV;
OMIM# 133200), which is caused by
mutations in the genes of either Cx31 or
Cx30.3 (Richard et al., 1998a; Macari
et al., 2000) In addition, mutations in
Cx26, which are the leading cause of
nonsyndromic deafness, were also as-
sociated with a variety of skin disorders
including palmoplantar keratoderma
associated with sensorineural hearing
loss (PPK; OMIM 148350, Richard
et al., 1998b), keratitis–ichthyosis–deaf-
ness syndrome (KID syndrome; OMIM
148210; Richard et al., 2002; van
Steensel et al., 2002), Bart–Pumphrey
syndrome (OMIM 149200; Richard
et al., 2004), and Vohwinkel syndrome
(OMIM 124500; Maestrini et al., 1999).
Mutations in the Cx30 gene are the
basis of Clouston syndrome, which is
also known as ‘‘hidrotic ectodermal
dysplasia’’ (OMIM 129500; Lamartine
et al., 2000). Finally, palmoplantar
keratoderma, focal hyperkeratosis, and
kinky hair have been described in
oculo–dento–digital dysplasia, which is
a rare, complex developmental disorder
mainly affecting the face, eyes, teeth,
hair, and limbs and is caused by
mutations in the Cx43 gene (Paznekas
et al., 2003; Gong et al., 2006; Kelly
et al., 2006; Table 1). In this review, we
will briefly summarize the known
changes in functional activity of mutant
connexin proteins that produce the
various skin disorders.
Functional analyses of specific
pathogenic connexin mutations asso-
ciated with skin anomalies have been
conducted to decipher the molecular
mechanisms underlying these diseases
and to highlight the normal role of
intercellular communication in the
epidermis. In contrast to connexin
mutations causing skin disorders, auto-
somal recessive hearing loss without
skin involvement (nonsyndromic) is
often because of a simple loss of
channel function altering cochlear in-
tercellular communication (White,
2000; Bruzzone et al., 2003), suggest-
ing that loss of connexin function is not
detrimental for development and func-
tion of the epidermis. Thus, mutant
connexin proteins resulting in skin
disorders must acquire novel functions
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not present in wild-type channels to
generate epidermal abnormalities.
In Xenopus oocyte expression stu-
dies, three Cx26 mutants causing PPK
and SNHL, R75W, delE42, and D66H,
were found not only to lack gap
junction channel function but also
inhibited coexpressed wild-type Cx26
(Richard et al., 1998b) in a dominant-
negative fashion, thus illustrating a
unique molecular mechanism for the
contribution of these mutations to skin
disease (Rouan et al., 2001). When
these mutants were coexpressed with
another epidermal connexin, Cx43,
they also produced a strong inhibition
of Cx43 channel activity (Rouan et al.,
2001). This suggested that PPK-asso-
ciated Cx26 mutations might perform
their action through a common me-
chanism where they act as trans-domi-
nant inhibitors of other epidermal
connexins, such as Cx43.
Analysis of the Cx26 mutations
G59A and D66H in Vohwinkel syn-
drome provided further insight about
the generation of distinct skin pheno-
types (Thomas et al., 2004). Lucifer
yellow dye transfer experiments de-
monstrated that these mutants failed to
form functional channels. Coexpres-
sion with Cx26, Cx43, or Cx32 showed
that both G59A and D66H exerted a
dominant-negative action on Cx26,
whereas having selective trans-domi-
nant effects on the other two connex-
ins. G59A reduced dye transfer
between cells when coexpressed with
either Cx32 or Cx43. In contrast, D66H
mutants had a dominant-inhibitory
effect only on Cx43 (Thomas et al.,
2004). The differential ability of each
mutation to affect distinct connexins
may explain variations in epidermal
phenotypes, or disease severity of
specific mutations. Similar trans-domi-
nant interactions were observed for
other epidermal disease-causing con-
nexin genes. The EKV-associated
Cx30.3 mutation F137L caused a re-
duction in the number and size of gap
junctions formed, as well as decrease
in coupling of HeLa cells when coex-
pressed with wild-type Cx31, suggest-
ing a distinct trans-dominant inhibitory
mechanism for this mutation (Plantard
et al., 2003). Thus, the spectrum of
trans-dominant interactions produced
by distinct connexin mutations could
uniquely alter the magnitude of inter-
cellular communication and/or the
range of permeable molecules shared
between epidermal keratinocytes, lead-
ing to specific skin disorders such as
PPK and EKV.
More evidence for the importance of
dominant-negative action on coex-
pressed connexins came from the only
animal model of a connexin skin
disorder to date, mimicking Vohwinkel
syndrome due to the expression of
Cx26-D66H in transgenic mice (Bakirt-
zis et al., 2003). Cx26-D66H trans-
genic mice displayed premature
keratinocyte cell death with a thicken-
ing of epidermal layers (hyperkerato-
sis), similar clinical features to human
patients with heterozygous D66H mu-
tations in GJB2 (Cx26). Accumulation
of Cx26-D66H protein was observed
in the cytoplasm of keratinocytes, im-
Table 1. Epidermal connexins and associated disorders
Gene Hereditary disease
OMIM
reference Expression pattern
GJB4(Cx30.3) Autosomal-dominant erythrokeratodermia variabilis 133200 Skin, kidney, and placenta
GJB3(Cx31) Autosomal-dominant and -recessive
erythrokeratodermia variabilis
133200 Skin, cochlea, placenta, kidney, testes, eye, and
PNS
Autosomal-dominant and -recessive nonsyndromic
sensorineural hearing loss (DFNA3)
600101
GJB2(Cx26) Autosomal-recessive nonsyndromic sensorineural
hearing loss (DFNB1)
220290
Autosomal-dominant nonsyndromic sensorineural
hearing loss (DFNA3)
601544 Almost ubiquitous, including cochlea, skin,
liver, placenta, breast, lung, and brain
Vohwinkel syndrome 124500
Keratitis–ichthyosis–deafness syndrome 148210
Palmoplantar keratoderma associated with
sensorineural hearing loss
148350
Bart–Pumphrey syndrome 149200
GJB6(Cx30) Autosomal-recessive nonsyndromic sensorineural
hearing loss (DFNB1)
220290
Autosomal-dominant nonsyndromic sensorineural
hearing loss (DFNA3)
601544 Skin, brain, cochlea, and cornea
Clouston syndrome (Hidrotic ectodermal dysplasia) 129500
GJA1(Cx43) Oculo–dento–digital dysplasia 164200 Ubiquitous, including skin, heart, eye, and brain
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plicating defective trafficking of the
protein to the plasma membrane.
Moreover, transgenic Cx26-D66H ex-
erted a dominant-negative effect on
both Cx26 and Cx30, also inhibiting
the transport of these wild-type proteins
to the cell membrane. Surprisingly,
Cx26-D66H did not interfere with
Cx43 membrane localization (Bakirtzis
et al., 2003), despite dominantly in-
hibiting Cx43 channel formation in two
separate in vitro assays (Rouan et al.,
2001). These results underscore the
importance of animal models in con-
firming molecular mechanisms and
suggest that additional research will
be required to fully understand the
pathogenicity of the D66H mutation.
EKV-associated Cx31 mutations
were also shown to impair protein
trafficking. The recessive L34P muta-
tion caused protein accumulation in
the cytoplasm and prevented the for-
mation of functional Cx31 intercellular
channels (Gottfried et al., 2002). Char-
acterization of dominant Cx31 EKV
mutations such as R42P, 66delD,
G12R, G12D, and C86S further pro-
vided support for the role of impaired
protein trafficking in this disease (Di
et al., 2002). Mutant proteins showed
an aberrant cytoplasmic localization
and cells expressing mutant proteins
had a high incidence of cell death. The
defective trafficking and cell death
were also detected in cells expressing
Cx26 keratitis–ichthyosis–deafness-as-
sociated mutants, G12R, S17F, and
D50N (Common et al., 2003). The
reason for cell death has not been
elucidated; however, the defective pro-
teins may influence the functionality of
other connexins or other cellular com-
ponents or alter the hemichannel func-
tion, thus leading to the observed skin
pathologies.
In addition to having an impact on
the function or assembly of gap junc-
tion channels, some connexin muta-
tions may promote the activity of
hemichannels. Support for this idea
came from studies of a Cx26 KID
syndrome mutation, A40V. Injection
of A40V complementary RNA into
Xenopus oocytes resulted in a disorga-
nization of cell pigmentation followed
by cell death. Moreover, induction of
large membrane currents not seen in
wild-type Cx26 suggested the presence
of aberrant A40V hemichannel activity
(Montgomery et al., 2004). The authors
concluded that constitutively active
hemichannels could contribute to the
pathophysiology of this mutation.
Functional evaluation of additional
KID syndrome mutations in Cx26 will
be needed to determine if this is a
general mechanism for this disorder, as
dominant inhibition seems to be for
PPK. However, further support for
disregulated hemichannels playing a
role in pathology has emerged from
studies of other skin disorders.
Similar to the A40V Cx26 mutation,
the hidrotic ectodermal dysplasia-asso-
ciated Cx30 mutants G11R and A88V-
induced cell death in Xenopus oocytes,
which could have resulted from the
presence of functional hemichannels,
an idea supported by the detection of
large voltage-activated currents in sin-
gle oocytes expressing mutant proteins
that were not seen in cells injected with
wild-type Cx30 (Essenfelder et al.,
2004). These currents could be sup-
pressed by elevation of extracellular
calcium, and under these conditions,
G11R and A88V formed functional
intercellular channels with altered vol-
tage gating properties. Further support
for active hemichannels came from the
analysis of ATP leakage in HeLa cells
transfected with G11R and A88V. Cells
expressing mutant channels had an
ATP leakage two to threefold higher
than control cells, suggesting that ATP
release through hemichannels may
play a role in the hidrotic ectodermal
dysplasia phenotype (Essenfelder et al.,
2004). Aberrant channel activity was
also observed for the EKV-associated
Cx31 mutant G12R (Diestel et al.,
2002). Cells expressing G12R started
to die B48 hours after initiation of
protein synthesis. The mutant channels
displayed increased neurobiotin per-
meability 24 hours after protein expres-
sion relative to wild-type Cx31. This
elevated junctional communication
was proposed to be because of reduc-
tion or disruption of channel gating.
However, these cells were not exam-
ined for functional hemichannels,
which might have contributed to cell
death. In addition to causing cell
depolarization and death, hemichan-
nels could induce the release of meta-
bolites into the extracellular space in
the epidermis and influence the regula-
tion of keratinocyte growth and differ-
entiation.
The etiology of several human her-
editary skin diseases has been linked to
mutations in a variety of connexin
genes and different mutations within a
single connexin gene can generate a
range of functional defects, implicating
that diverse channel activities contri-
bute to the different disorders. Accu-
mulating evidence shows that the
mutations associated with distinct skin
phenotypes give rise to novel func-
tional activities. Three mechanisms
could be proposed for the action of
skin disease-associated mutations: (i)
impaired protein trafficking and con-
nexon assembly at the plasma mem-
brane, (ii) trans-dominant inhibition of
coexpressed connexins, and (iii) the
production of constitutively active
hemichannels, any or all of which
could potentially alter cell survival
(Figure 3). The trans-dominant inhibi-
tory actions of mutant proteins change
the range of channel types available in
the epidermis, and therefore may alter
the type of molecules exchanged and
also the extent of intercellular commu-
nication. Leaky hemichannels might
cause uncontrolled release of cell con-
tents including metabolites and signal-
ing molecules into the extracellular
space, which could affect the behavior
of surrounding cells in addition to
initiating cell death.
In the adult human epidermis, con-
nexins have distinct as well as over-
lapping expression patterns (Figure 4).
Under pathological conditions, the
normal distribution of connexins may
be altered. For example, a PPK patient
with a Cx26-E42del mutation showed
ectopic expression of Cx26 in the
spinous and granular layers, where
Cx26 was found to colocalize with
Cx43 (Rouan et al., 2001). Colocaliza-
tion of Cx26 with Cx43 in PPK lesions
owing to upregulation of Cx26 could
promote the interaction of Cx26 mutant
protein with Cx43, altering its assembly
or channel activity, consistent with in
vitro studies showing a trans-dominant
inhibition of Cx43 by Cx26 mutants
(Rouan et al., 2001). The resulting
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alteration of gap junctional communi-
cation could modify the natural re-
sponse pattern of keratinocytes during
terminal differentiation and in response
to stress or injury. It still remains
unclear, however, how subtle changes
in intercellular signal transmission
within the upper layers of the epidermis
result in epidermal thickening
(acanthosis). Upregulation of Cx26 in
keratinocytes preceding hyperprolifera-
tion has been observed during wound
healing and inflammatory skin disor-
ders (Labarthe et al., 1998; Djalilian
et al., 2006). However, the relationship
between the Cx26 upregulation and
keratinocyte proliferation is not fully
known, and the signaling cascades and/
or molecules that could play role in this
process remain to be identified. Exam-
ination of skin samples from patients
with other connexin-based disorders,
such as EKV or hypohidrotic ectoder-
mal dysplasia, may further demonstrate
if alterations in the connexin expres-
sion and distribution are a common
feature of skin diseases. Additional
characterization of disease-causing
mutations and the generation and ex-
amination of transgenic animals
will further improve our understanding
of the function of gap junctional com-
munication in keratinocyte growth and
differentiation as well as the pathophy-
siology of diseases, where control of
these processes has been corrupted.
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